Clinical Trials Browser

OTHER × Azacitidine × Head & Neck × Clear all

NCT05317000 2026-01-12

5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck

NCT03019003 2025-09-16

Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients

Phase 1 Completed

13 enrolled 12 charts

Head and Neck Neoplasms

NCT04729543 2023-12-04

MC2TCR

Phase 1/2 Recruiting

DermatologicHead & Neck

Uveal Melanoma, Head and Neck Neoplasms, Melanoma

NCT02178072 2022-02-15

Window Trial 5-aza in HNSCC, T-tare

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00901537 2018-04-17

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer

Phase 1 Terminated

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT00443261 2017-02-27

Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Phase 1 Terminated

1 enrolled 5 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms